XML 45 R35.htm IDEA: XBRL DOCUMENT v3.22.2.2
Revenue Recognition (Tables)
9 Months Ended
Sep. 30, 2022
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
The following table represents Evolent’s revenue disaggregated by segment and end-market for (in thousands):
For the Three Months Ended September 30,For the Nine Months Ended September 30,
20222021202220212022202120222021
Evolent Health ServicesClinical SolutionsEvolent Health ServicesClinical Solutions
Medicaid$60,054 $41,857 $79,664 $51,829 $183,542 $154,850 $226,684 $148,816 
Medicare6,335 4,816 111,632 105,219 21,031 19,500 315,334 281,763 
Commercial and other40,939 16,184 53,961 2,566 101,948 48,207 121,042 6,463 
Total$107,328 $62,857 $245,257 $159,614 $306,521 $222,557 $663,060 $437,042 
Schedule of Contract with Customer, Asset and Liability
The following table provides information about receivables, contract assets and deferred revenue from contracts with customers as of September 30, 2022 and December 31, 2021 (in thousands):
September 30, 2022December 31, 2021
Short-term receivables (1)
$185,590 $129,012 
Long-term receivables (1)
884 4,877 
Short-term deferred revenue7,524 11,944 
Long-term deferred revenue3,185 4,437 
————————
(1)Excludes pharmacy claims receivable and premiums receivable.
Changes in deferred revenue for the nine months ended September 30, 2022 are as follows (in thousands):
Deferred revenue
Balance as of beginning-of-period$16,381 
Reclassification to revenue, as a result of performance obligations satisfied(11,445)
Cash received in advance of satisfaction of performance obligations5,773 
Balance as of end of period$10,709